Migralgin (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces central prostaglandin production, lowering pain perception and fever. Aspirin irreversibly inhibits peripheral cyclooxygenase, decreasing inflammation and platelet aggregation. Caffeine blocks adenosine receptors, providing mild stimulation and increasing the analgesic potency of the other two ingredients, resulting in faster and stronger symptom control.

The appropriate dose of Migralgin is determined by the prescribing healthcare professional based on the individual’s age, weight, medical history and the severity of symptoms. Patients should follow the prescriber’s instructions and never exceed the recommended amount on the product label.

Safety of Migralgin in pregnancy or while breastfeeding has not been definitively established. Women who are pregnant, planning pregnancy, or nursing should consult their physician before using the product to weigh potential benefits against possible risks.

To order Migralgin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient analgesics, Migralgin combines paracetamol, aspirin and caffeine, offering a broader mechanism of action that can provide faster and more complete relief for headache and migraine. It may be preferred when a patient needs both anti‑inflammatory and antipyretic effects, but individual response and tolerance vary.

Migralgin should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and heat. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Migralgin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may prefer taking it with a meal. The exact timing and frequency should follow the prescriber’s directions.

Serious risks include allergic reactions such as rash, swelling or anaphylaxis, gastrointestinal bleeding or ulceration, severe liver injury, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice any of these severe symptoms.

Migralgin should be avoided by individuals with known hypersensitivity to paracetamol, aspirin or caffeine, those with active peptic ulcer disease, severe liver or kidney impairment, uncontrolled hypertension, and patients on anticoagulant therapy unless advised by a physician.